Feedback / Questions
ABX1100 - Aro Biotherap
https://www.businesswire.com/news/home/20250123591368/en/Aro-Biotherapeutics-Doses-First-Patient-in-Phase-1b-Trial-of-ABX1100-in-Late-Onset-Pompe-Disease-LOPD
Jan 23, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next